Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

tDCS to Decrease Opioid Relapse (UH3) — Stella

Home/Opioid Use Disorder/tDCS to Decrease Opioid Relapse (UH3)

View on ClinicalTrials.gov

Recruiting

Back to Opioid Use Disorder trials

tDCS to Decrease Opioid Relapse (UH3)

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Butler Hospital, Providence, Rhode Island

Key details

Sponsor

Butler Hospital

Collaborators

National Institute on Drug Abuse (NIDA)

Enrollment target

~100 participants

Started

April 2024

Primary completion

December 2026

Age range

21 Years – 60 Years

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.